array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(14) "ELEKTA LIMITED"
["slug"]=>
string(23) "dbe4b-gb-elekta-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7"
["description"]=>
string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more."
["address_street"]=>
string(11) "Linac House"
["address_place"]=>
string(7) "CRAWLEY"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1996-09-02"
["website_domain"]=>
string(10) "elekta.com"
["website_url"]=>
string(22) "https://www.elekta.com"
["industry_codes"]=>
array(1) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
}
["employee_count"]=>
int(820)
["article_count"]=>
int(550)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(83) "SHB buys Elekta in the short term - believes in improved prospects in the near term"
["snippet_en"]=>
string(104) "Handelsbanken raises its short-term recommendation for the medical technology company Elekta to buy from"
["url"]=>
string(110) "https://nyheter24.se/ekonomi/1248683-shb-kopstamplar-elekta-pa-kort-sikt-tror-pa-forbattrade-utsikter-i-nartid"
["image_url"]=>
NULL
["source"]=>
string(12) "nyheter24.se"
["publication_date"]=>
string(10) "2024-03-01"
["categories"]=>
array(1) {
[0]=>
string(11) "Acquisition"
}
}
[1]=>
array(7) {
["title_en"]=>
string(63) "GE HealthCare partners with Elekta to enhance radiation therapy"
["snippet_en"]=>
string(105) "Elekta’s radiation therapy offerings will now utilize GE HealthCare’s recently acquired MIM software."
["url"]=>
string(83) "https://www.mobihealthnews.com/news/ge-healthcare-partners-elekta-radiation-therapy"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/119f9992-6c09-455a-b08e-260360293a53"
["source"]=>
string(18) "mobihealthnews.com"
["publication_date"]=>
string(10) "2024-02-04"
["categories"]=>
array(3) {
[0]=>
string(18) "Expansion & Growth"
[1]=>
string(11) "Acquisition"
[2]=>
string(13) "Collaboration"
}
}
[2]=>
array(7) {
["title_en"]=>
string(113) "Elekta Expands Market and Treatment Application of Brachytherapy with Acquisition of iCAD, Inc.’s Xoft Business"
["snippet_en"]=>
string(299) "October 23, 2023 — Elekta announced it has acquired the Xoft business from iCAD, Inc. through an asset acquisition. By acquiring the Xoft Axxent Electronic Brachytherapy( eBx) System, together with the transfer of employees, Elekta, the world leader in brachytherapy solutions, will now be able to"
["url"]=>
string(131) "https://www.itnonline.com/content/elekta-expands-market-and-treatment-application-brachytherapy-acquisition-icad-inc%E2%80%99s-xoft"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/49929b6b-8dd7-40d2-8d60-2ddcc210ca1f"
["source"]=>
string(13) "itnonline.com"
["publication_date"]=>
string(10) "2023-10-23"
["categories"]=>
array(7) {
[0]=>
string(20) "Business Development"
[1]=>
string(23) "Supply Chain Management"
[2]=>
string(21) "Competitive Behaviour"
[3]=>
string(18) "Expansion & Growth"
[4]=>
string(11) "Acquisition"
[5]=>
string(25) "Business Model Resilience"
[6]=>
string(15) "Market Movement"
}
}
[3]=>
array(7) {
["title_en"]=>
string(48) "iCad sells Xoft brachytherapy business to Elekta"
["snippet_en"]=>
string(107) "iCad today announced it sold its Xoft Brachytherapy business line to Elekta for approximately $5.5 million."
["url"]=>
string(76) "https://www.massdevice.com/icad-sells-xoft-brachytherapy-business-to-elekta/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/81acbec2-d388-4773-a92c-c464828e836b"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2023-10-23"
["categories"]=>
array(6) {
[0]=>
string(18) "Business Structure"
[1]=>
string(20) "Business Development"
[2]=>
string(11) "Acquisition"
[3]=>
string(25) "Business Model Resilience"
[4]=>
string(10) "Divestment"
[5]=>
string(22) "Business Restructuring"
}
}
[4]=>
array(7) {
["title_en"]=>
string(14) "Today's shrimp"
["snippet_en"]=>
string(137) "SEB raises Elekta to buy and raises its target price for Swedbank. Here is a summary of Tuesday's recommendation and target rate changes."
["url"]=>
string(69) "https://www.di.se/live/seb-hojer-elekta-till-kop-har-ar-dagens-rekar/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/beb29ae3-3d0d-485d-8e65-4d326e6095b6"
["source"]=>
string(5) "di.se"
["publication_date"]=>
string(10) "2023-09-26"
["categories"]=>
array(3) {
[0]=>
string(13) "Credit Rating"
[1]=>
string(11) "Acquisition"
[2]=>
string(12) "Stock Market"
}
}
[5]=>
array(7) {
["title_en"]=>
string(36) "Elekta takes off after analyst calls"
["snippet_en"]=>
string(52) "At most up 8.6 percent without company-specific news"
["url"]=>
string(67) "https://www.privataaffarer.se/elekta-lyfter-efter-analytikersamtal/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b123dc6e-3b4b-43c6-9c83-4e70cf984edc"
["source"]=>
string(17) "privataaffarer.se"
["publication_date"]=>
string(10) "2023-01-24"
["categories"]=>
array(1) {
[0]=>
string(11) "Acquisition"
}
}
[6]=>
array(7) {
["title_en"]=>
string(58) "Correction regarding press release: Québec to acquire ..."
["snippet_en"]=>
string(130) "Correction regarding press release: Québec to acquire advanced linear accelerators to meet growing need for advanced cancer care."
["url"]=>
string(182) "https://www.elekta.com/pressreleases/01A6768E0F312BE9/correction-regarding-press-release-quebec-to-acquire-advanced-linear-accelerators-to-meet-growing-need-for-advanced-cancer-care/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/7ffe7365-b2fe-4700-a7f0-6a29286741f3"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2020-02-17"
["categories"]=>
array(2) {
[0]=>
string(11) "Acquisition"
[1]=>
string(15) "Deals & Tenders"
}
}
[7]=>
array(7) {
["title_en"]=>
string(86) "Alliance Cancer Care to upgrade cancer care in southeastern U.S. with Elekta solutions"
["snippet_en"]=>
string(246) "HUNTSVILLE 2017-06-20 Collaboration to create a state-of-the-art linac-based stereotactic radiosurgery program Elekta( EKTA-B.ST) announced today that Alliance Cancer Care( ACC) has acquired advanced treatment and software solutions to best serve"
["url"]=>
string(151) "https://www.elekta.com/press/f76e8b90-0816-4452-b867-b6b2f1a5f839/alliance-cancer-care-to-upgrade-cancer-care-in-southeastern-u-s-with-elekta-solutions"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/73c5ccfd-673b-4c90-bb3d-829d927b4fd9"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2017-06-20"
["categories"]=>
array(3) {
[0]=>
string(16) "Aging Population"
[1]=>
string(11) "Acquisition"
[2]=>
string(13) "Collaboration"
}
}
[8]=>
array(7) {
["title_en"]=>
string(80) "Okan University Hospital to treat cancer with Elekta radiation therapy equipment"
["snippet_en"]=>
string(248) "Istanbul
2016-04-14
New Turkish medical school acquires Elekta Versa HD and Synergy linear accelerators
Okan University in Istanbul has recently signed an agreement to acquire Versa HD™ and Elekta Synergy® linear accelerators (linacs). The"
["url"]=>
string(146) "https://www.elekta.com/press/ef0d56f6-6235-4a9f-be65-227419b75b16/okan-university-hospital-to-treat-cancer-with-elekta-radiation-therapy-equipment"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1497c2dc-3c0a-4877-ae55-cdcae739ee0c"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2016-04-14"
["categories"]=>
array(2) {
[0]=>
string(17) "Academic Research"
[1]=>
string(11) "Acquisition"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(35)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(25)
}
[2]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(23)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(19)
}
[4]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(16)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[7]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(14)
}
[8]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(11)
}
[9]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(11)
}
[10]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(11)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[12]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(8)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[14]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(6)
}
[15]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(6)
}
[17]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(6)
}
[18]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[19]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(5)
}
[20]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[21]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[22]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(4)
}
[23]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(4)
}
[24]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(4)
}
[25]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(3)
}
[26]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(3)
}
[27]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(3)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(21) "Intellectual Property"
["count"]=>
int(2)
}
}
}
dbe4b-gb-elekta-limited
ELEKTA LIMITED
Location
Founded
1996-09-02
Website
https://www.elekta.com
Articles
550 Articles
Category
Surgical and Medical Instruments and Apparatus
Description
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.
October 23, 2023 — Elekta announced it has acquired the Xoft business from iCAD, Inc. through an asset acquisition. By acquiring the Xoft Axxent Electronic Brachytherapy( eBx) System, together with the transfer of employees, Elekta, the world leader in brachytherapy solutions, will now be able to
HUNTSVILLE 2017-06-20 Collaboration to create a state-of-the-art linac-based stereotactic radiosurgery program Elekta( EKTA-B.ST) announced today that Alliance Cancer Care( ACC) has acquired advanced treatment and software solutions to best serve
Istanbul
2016-04-14
New Turkish medical school acquires Elekta Versa HD and Synergy linear accelerators
Okan University in Istanbul has recently signed an agreement to acquire Versa HD™ and Elekta Synergy® linear accelerators (linacs). The
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
